XTX Topco’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
XTX Topco's ACAD Position: Q3 2026 in Review
XTX Topco opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 28,435 shares worth $573K. The stake represents 0.01% of the portfolio and ranks #2258 among its holdings. This is a return to the name: XTX Topco previously reported a position in ACAD as recently as Q2 2024.
XTX Topco first reported a position in ACAD in Q2 2021 and has held it in 8 quarters since. The position peaked at $749K in Q3 2023. 351 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- XTX Topco held 28,435 shares of Acadia Pharmaceuticals worth $573K as of Q3 2026.
- Acadia Pharmaceuticals was a new XTX Topco position in Q3 2026.
- Acadia Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q3 2026, its #2258 holding.
- XTX Topco first reported a position in Acadia Pharmaceuticals in Q2 2021 and has held it in 8 quarters since.
- XTX Topco's Acadia Pharmaceuticals position peaked at $749K in Q3 2023.
- 351 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.